For full transcript refer to earlier post here. This particular segment comes from the direct and cross examination of David Healy.
Apologies in advance for the poor formatting of this post.
Mr Tracey is Attorney for the plaintiffs [Kilker's]
Ms Chilton is Attorney for the defendants [GlaxoSmithKline]
(Jury enters courtroom at 2:05 p.m.)
BY MR. TRACEY:
Q. Dr. Healy, who's Dr. Charles Nemeroff?
A. Dr. Charles Nemeroff was the Chief of Psychiatry from University of Emory down in Georgia.
Q. He is a psychiatrist?
A. He is. He's possibly best known or was the best known psychiatrist in the United States.
Q. Was he an influential psychiatrist?
A. Extremely influential.
Q. Who did he influence?
13 A. He influenced an awful lot of heads of departments, professors of psychiatry, general people within the field of academic mental health, and through them and an awful lot of prescribing doctors here in the U.S. And, indeed, perhaps worldwide.
Q. Was he the kind of doctor that if people wanted to know something about psychiatry, they looked up what he wrote so they could get his opinions?
A. His views would have been extremely influential.
Q. Was he on the GlaxoSmithKline advisory board?
A. Yes, he was. He was there from the start.
Q. Was he one of the founding members of the Paxil advisory board?
A. He was, I believe.
Q. Did he get paid for all of this?
A. He did.
Q. Did he do CMEs on Paxil?
A. He was involved -- he would have been the key person in producing the kinds of talks with slides that would have been held for large audiences of doctors, and then those slides and talks would have been distributed out to different doctors in the field who hadn't been at the major meetings as he gave his talk.
Q. Doctor, if you will turn to, I think, it's Tab 19.
MR. TRACEY: This is Plaintiff's Exhibit 337, if there is no objection.
MS. CHILTON: Same objection as before, Your Honor.
THE COURT: Overruled.
BY MR. TRACEY:
Q. Is Dr. Nemeroff here M.D., Ph.D, the Reunette Harris Professor and Chair Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia?
A. Yes.
Q. You actually know Dr. Nemeroff, don't you?
A. Yes.
Q. You talked to him and met him at meetings?
A. Over a 20-odd year period we met quite often. The most recent would have been actually May this year.
Q. Now, as Dr. Nemeroff -- do you know whether Dr. Nemeroff is still the chairman of the Department of Psychiatry at Emory?
A. Yes, I do know.
Q. Is he?
A. No, he is not.
Q. When did he lose the position?
A. He lost the position in the course of the last year.
Q. This particular document it says up top a CME.
Q. What is a CME?
A. That stands for continuing medical education.
Q. This is where doctors will go to hear other doctors speak on topics relevant to their practice?
A. That's correct.
Q. And the name of this document or this CME is Fertility, Mood and Motherhood?
A. That's correct.
Q. Do we know, in looking at the document, whether there was any GSK involvement in the material?
A. We do know that this material was prepared for Dr. Nemeroff, yes.
Q. By GSK?
A. Yes; and through them, agencies like STI, for instance.
Q. When I look at the -- when I actually look at the document, it's about 15 pages long, is there a place to put in this document, in this CME who were the people that wrote it or put it together or did the slides?
A. No, I think most doctors looking at this would assume it was prepared by Dr. Nemeroff.
Q. All right. If you can turn to Tab 23.
MR. TRACEY: This is Plaintiff's Exhibit 1661, Your Honor, which plaintiffs
will move to admit.
THE COURT: Wait a second, please. Going back to the other document for a second, sir, the last page, does not the document indicate that it was supported through an unrestricted educational grant from SmithKline Beecham Pharmaceutical?
THE WITNESS: Yes, it does.
THE COURT: Go to your next questions.
BY MR. TRACEY:
Q. That's on the last page of that document, Doctor, right?
A. Yes.
Q. To be clear, the last page of the document says that the materials were provided by SmithKline Beecham.
A. No, it says supported by unrestricted educational grant. That Dr. Nemeroff was reimbursed for his role in this.
Q. I see; okay.
----
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
Zantac Lawsuit
Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist
Please contact me if you would like a guest post considered for publication on my blog.
1 comment: